US 9855312
GHRH agonists for the treatment of ischemic disorders
granted A61KA61K38/16A61K38/25
Quick answer
US patent 9855312 (GHRH agonists for the treatment of ischemic disorders) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- Grant date
- Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/16, A61K38/25